I am a Wellcome Trust research fellow at KEMRI-Wellcome Trust research programme and the University of Oxford.
My main research interests are in the development and validation of prognostic biomarkers for acute respiratory infections in infants. I am also involved in early preclinical development of virus vectored vaccines for respiratory syncytial virus (RSV) and have previously worked in the clinical evaluation of first-in-man vaccine studies of RSV in early phase I trials. Prior to that I undertook studies on the development of protective immunity to RSV infants.
Absence of association between cord specific antibody levels and severe respiratory syncytial virus (RSV) disease in early infants: a case control study from coastal Kenya.
Nyiro, J.U., Sande, C.J., Mutunga, M., Kiyuka, P.K., Munywoki, P.K., Scott, J.A.G. and Nokes, D.J.
PLoS One, 11(11), p.e0166706 (2016)
Non-specific immunological effects of selected routine childhood immunisations: systematic review.
Kandasamy, R., Voysey, M., McQuaid, F., de Nie, K., Ryan, R., Orr, O., Uhlig, U., Sande, C., O’Connor, D. and Pollard, A.J.
bmj, 355, p.i5225 (2016)
Best practice in the prevention and management of paediatric respiratory syncytial virus infection.
Drysdale, S.B., Green, C.A. and Sande, C.J.
Therapeutic advances in infectious disease, p.2049936116630243 (2016)
RSV vaccine use–the missing data.
Drysdale, S.B., Sande, C.J., Green, C.A. and Pollard, A.J.
Expert review of vaccines, 15(2), pp.149-152 (2016)
Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma.
Green, C.A., Yeates, D., Goldacre, A., Sande, C., Parslow, R.C., McShane, P., Pollard, A.J. and Goldacre, M.J.
Archives of disease in childhood, pp.archdischild-2015 (2015)
--> view all Dr. Charles Sande's publications